Thursday, September 16, 2021 5:46:47 PM
New York Yankees and Duke Basketball
Recent ABCL News
- AbCellera to Present at Upcoming Investor Conferences in November 2024 • Business Wire • 10/22/2024 08:05:00 PM
- AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 • Business Wire • 10/04/2024 01:00:00 PM
- AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 • Business Wire • 09/26/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/24/2024 08:09:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 08:35:34 PM
- AbCellera to Present at Upcoming Investor Conferences in September • Business Wire • 08/29/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:26:59 PM
- AbCellera Reports Q2 2024 Business Results • Business Wire • 08/06/2024 08:05:00 PM
- AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines • Business Wire • 07/31/2024 01:00:00 PM
- AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 • Business Wire • 06/25/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:53:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:21:18 PM
- AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:47:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:22:22 PM
- AbCellera Reports Q1 2024 Business Results • Business Wire • 05/07/2024 08:05:00 PM
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies • Business Wire • 05/01/2024 01:00:00 PM
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 • Business Wire • 04/08/2024 04:05:00 PM
- AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 • Business Wire • 04/03/2024 08:05:00 PM
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 • Business Wire • 03/19/2024 08:05:00 PM
- AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions • Business Wire • 03/11/2024 01:00:00 PM
- AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 • Business Wire • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:49:40 PM
FEATURED Element79 Gold Corp Shares Further Advances With Chachas Community on Lucero Surface Rights, Provides Corporate Update • Oct 28, 2024 10:25 AM
VAYK Clarifies It Has No Business Connection to Persons Under SEC Charge • VAYK • Oct 28, 2024 11:59 AM
Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM
VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM